Exscientia Ltd ADR (EXAI) said before open Thursday that it broke even in quarter four 2023.
In the same quarter a year ago, the company lost $0.38 per share on revenue of $8.2 million.
The stock is down 14.31% to $6.86 after the report.
The firm's lower revenue growth to earnings signals that the firm has been able to reduce costs and improve its profit margin overall.
Wall Street Analysts had an average rating of Buy on the stock prior to the report.
InvestorsObserver gives the stock a Bullish Sentiment score at the moment based on recent trading.
Prior to the report, InvestorsObserver gave the stock an overall score of 56. Meanwhile, the average Wall Street analyst rated the stock a Buy.
Exscientia PLC is an artificial intelligence-driven pharma tech company committed to discovering, designing, and developing drugs.
News Home
Exscientia Ltd ADR Down 14.31% To $6.86 After Earnings
Mentioned in this article
